TD Asset Management Portfolio holdings
AUM
$117B
1-Year Return
25.17%
This Quarter Return
+1.82%
1 Year Return
+25.17%
3 Year Return
+87.06%
5 Year Return
+156.45%
10 Year Return
+305.53%
AUM
$113B
AUM Growth
-$291M
(-0.26%)
Cap. Flow
-$48.7M
Cap. Flow
% of AUM
-0.04%
Top 10 Holdings %
Top 10 Hldgs %
26.07%
Holding
1,436
New
51
Increased
634
Reduced
495
Closed
194
Top Buys
| 1 |
Invesco Senior Loan ETF
BKLN
|
+$392M |
| 2 |
Ares Management
ARES
|
+$226M |
| 3 |
SAP
SAP
|
+$219M |
| 4 |
Lam Research
LRCX
|
+$186M |
| 5 |
Apple
AAPL
|
+$158M |
Top Sells
| 1 |
KLA
KLAC
|
+$273M |
| 2 |
Toronto Dominion Bank
TD
|
+$247M |
| 3 |
AbbVie
ABBV
|
+$178M |
| 4 |
Intuit
INTU
|
+$109M |
| 5 |
Corebridge Financial
CRBG
|
+$99.7M |
Sector Composition
| 1 | Technology | 21.97% |
| 2 | Financials | 20.9% |
| 3 | Industrials | 10.1% |
| 4 | Healthcare | 9.35% |
| 5 | Consumer Discretionary | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Alector
ALEC
$283M
| $211K | ﹤0.01% |
111,738
| – | – |
|
|
CGC
1227
Canopy Growth
CGC
$452M
| $210K | ﹤0.01% |
76,510
+1,131
| +2% | +$3.1K |
|
1228
Prelude Therapeutics
PRLD
$67.4M
| $205K | ﹤0.01% |
160,652
| – | – |
|
1229
HealthStream
HSTM
$850M
| $204K | ﹤0.01% |
6,400
-1,700
| -21% | -$54.1K |
|
1230
Cabaletta Bio
CABA
$150M
| $201K | ﹤0.01% |
88,600
| – | – |
|
1231
AnaptysBio
ANAB
$619M
| $185K | ﹤0.01% |
14,000
-48,000
| -77% | -$636K |
|
|
CLYM
1232
Climb Bio, Inc. Common Stock
CLYM
$161M
| $161K | ﹤0.01% |
89,400
| – | – |
|
1233
Frontline
FRO
$5.01B
| $145K | ﹤0.01% |
10,547
+364
| +4% | +$5.02K |
|
1234
MacroGenics
MGNX
$109M
| $141K | ﹤0.01% |
43,400
-125,600
| -74% | -$408K |
|
1235
Day One Biopharmaceuticals
DAWN
$759M
| $137K | ﹤0.01% |
10,796
| – | – |
|
1236
Prime Medicine
PRME
$734M
| $136K | ﹤0.01% |
46,434
| – | – |
|
1237
Ginkgo Bioworks
DNA
$637M
| $128K | ﹤0.01% |
13,046
| – | – |
|
1238
Hafnia
HAFN
$3.08B
| $110K | ﹤0.01% |
20,514
+2,542
| +14% | +$13.6K |
|
|
CRON
1239
Cronos Group
CRON
$976M
| $24.8K | ﹤0.01% |
+12,350
| New | +$24.8K |
|
1240
Revolution Medicines, Inc. Warrant
RVMDW
$2.48M
| $6.57K | ﹤0.01% |
40,636
| – | – |
|
|
WGSWW
1241
GeneDx Holdings Corp. Warrant
WGSWW
$2.57M
| $5.58K | ﹤0.01% |
34,884
| – | – |
|
1242
Sonder Holdings Inc. Warrants
SONDW
$126K
| $1.08K | ﹤0.01% |
180,000
| – | – |
|
1243
PRA Group
PRAA
$660M
| – | – |
-32,058
| Closed | -$726K |
|
1244
Perdoceo Education
PRDO
$2.17B
| – | – |
-57,900
| Closed | -$1.28M |
|
1245
PROG Holdings
PRG
$1.38B
| – | – |
-47,700
| Closed | -$2.3M |
|
1246
Pricesmart
PSMT
$3.41B
| – | – |
-27,800
| Closed | -$2.54M |
|
1247
RAPT Therapeutics
RAPT
$225M
| – | – |
-1,533
| Closed | -$24K |
|
1248
Radian Group
RDN
$4.72B
| – | – |
-34,500
| Closed | -$1.2M |
|
1249
RPC Inc
RES
$1.01B
| – | – |
-34,600
| Closed | -$218K |
|
1250
REX American Resources
REX
$1.01B
| – | – |
-37,700
| Closed | -$1.74M |
|